BIOMAT Database Logo BIOMAT Database Logo

Respiratory culture nudge improves antibiotic prescribing for Moraxella catarrhalis and Haemophilus influenzae lower respiratory tract infections. 2023

Christen J Arena, and Rachel M Kenney, and Ronald E Kendall, and Robert J Tibbetts, and Michael P Veve
Department of Pharmacy, Henry Ford Health, Detroit, Michigan.

We compared optimal antibiotic prescribing before and after implementing an interpretive β-lactamase microbiology comment for Haemophilus influenzae and Moraxella catarrhalis in lower respiratory-tract infections. The postintervention group was associated with 5-fold increased odds of optimal de-escalation (adjusted odds ratio, 5.03; 95% confidence interval, 2.57-9.87).

UI MeSH Term Description Entries

Related Publications

Christen J Arena, and Rachel M Kenney, and Ronald E Kendall, and Robert J Tibbetts, and Michael P Veve
The other siblings: respiratory infections caused by Moraxella catarrhalis and Haemophilus influenzae.
May 2006, Current infectious disease reports,
Christen J Arena, and Rachel M Kenney, and Ronald E Kendall, and Robert J Tibbetts, and Michael P Veve
Complement evasion by the human respiratory tract pathogens Haemophilus influenzae and Moraxella catarrhalis.
August 2020, FEBS letters,
Christen J Arena, and Rachel M Kenney, and Ronald E Kendall, and Robert J Tibbetts, and Michael P Veve
The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections.
September 2002, The Journal of antimicrobial chemotherapy,
Christen J Arena, and Rachel M Kenney, and Ronald E Kendall, and Robert J Tibbetts, and Michael P Veve
Antibiotic resistance in respiratory tract isolates of Haemophilus influenzae and Moraxella catarrhalis collected from across Canada in 1997-1998.
May 2000, The Journal of antimicrobial chemotherapy,
Christen J Arena, and Rachel M Kenney, and Ronald E Kendall, and Robert J Tibbetts, and Michael P Veve
Quantitative detection of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in lower respiratory tract samples by real-time PCR.
July 2006, Diagnostic microbiology and infectious disease,
Christen J Arena, and Rachel M Kenney, and Ronald E Kendall, and Robert J Tibbetts, and Michael P Veve
Controlling antibiotic prescribing for lower respiratory tract infections.
May 2017, BMJ (Clinical research ed.),
Christen J Arena, and Rachel M Kenney, and Ronald E Kendall, and Robert J Tibbetts, and Michael P Veve
Vaccines for Moraxella catarrhalis and non-typeable Haemophilus influenzae.
August 2003, Current opinion in investigational drugs (London, England : 2000),
Christen J Arena, and Rachel M Kenney, and Ronald E Kendall, and Robert J Tibbetts, and Michael P Veve
Moraxella (Branhamella) catarrhalis: clinical, microbiological and immunological features in lower respiratory tract infections.
January 1999, APMIS. Supplementum,
Christen J Arena, and Rachel M Kenney, and Ronald E Kendall, and Robert J Tibbetts, and Michael P Veve
Cefaclor treatment of upper and lower respiratory tract infections caused by Moraxella catarrhalis.
January 1990, The Pediatric infectious disease journal,
Christen J Arena, and Rachel M Kenney, and Ronald E Kendall, and Robert J Tibbetts, and Michael P Veve
[The penicillin susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and Staphylococcus aureus in persons suffering from upper respiratory tract infections].
January 1998, Przeglad epidemiologiczny,
Copied contents to your clipboard!